Sanofi made the biggest leap up the corporate reputation in dermatology rankings ... Companies with new biologic skin-condition products such as Novartis and Janssen, or those expanding their ...

Regeneron and Sanofi's Dupixent sBLA for treating chronic spontaneous urticaria in patients 12+ gets FDA review, with a ...

Sanofi says that its experimental drug amlitelimab ... At the American Academy of Dermatology (AAD) congress in San Diego, data from STEAM-AD showed that amlitelimab achieved sustained improvement ...